- Home
- IBO vs EVOK Comparison
IBO vs EVOK Comparison
Compare IBO & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBO
- EVOK
- Stock Information
- Founded
- IBO 2018
- EVOK 2007
- Country
- IBO United States
- EVOK United States
- Employees
- IBO N/A
- EVOK N/A
- Industry
- IBO
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- IBO
- EVOK Health Care
- Exchange
- IBO NYSE
- EVOK Nasdaq
- Market Cap
- IBO 5.1M
- EVOK 4.2M
- IPO Year
- IBO 2024
- EVOK 2013
- Fundamental
- Price
- IBO $0.47
- EVOK $2.95
- Analyst Decision
- IBO
- EVOK
- Analyst Count
- IBO 0
- EVOK 0
- Target Price
- IBO N/A
- EVOK N/A
- AVG Volume (30 Days)
- IBO 505.9K
- EVOK 14.3K
- Earning Date
- IBO 06-13-2025
- EVOK 05-13-2025
- Dividend Yield
- IBO N/A
- EVOK N/A
- EPS Growth
- IBO N/A
- EVOK N/A
- EPS
- IBO N/A
- EVOK N/A
- Revenue
- IBO N/A
- EVOK $11,594,083.00
- Revenue This Year
- IBO N/A
- EVOK $57.82
- Revenue Next Year
- IBO N/A
- EVOK $59.12
- P/E Ratio
- IBO N/A
- EVOK N/A
- Revenue Growth
- IBO N/A
- EVOK 89.89
- 52 Week Low
- IBO $0.37
- EVOK $1.94
- 52 Week High
- IBO $6.17
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- IBO N/A
- EVOK 38.86
- Support Level
- IBO N/A
- EVOK $3.33
- Resistance Level
- IBO N/A
- EVOK $3.66
- Average True Range (ATR)
- IBO 0.00
- EVOK 0.29
- MACD
- IBO 0.00
- EVOK -0.06
- Stochastic Oscillator
- IBO 0.00
- EVOK 2.99
About IBO IMPACT BIOMEDICAL INC
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.